An Important Step Forward in the Research Field for the Treatment of Celiac Disease
Alvine Pharmaceuticals, Inc., a biopharmaceutical company which focuses on the treatment of gastrointestinal and autoimmune diseases, has been issued four key patents by the United States Patent and Trademark Office. Alvine Pharmaceuticals’ ALV003 development is key to designing a treatment for Celiac Disease.
Read More